Pain
Adults increasingly used complementary health approaches for pain over past 20 years
The overall use of several complementary health approaches, and their use for pain management specifically, rose substantially over the last couple of decades, researchers found.
FDA grants breakthrough therapy designation to opioid with ‘overdose protection’
The FDA has granted breakthrough therapy designation to PF614-MPAR, a “next-generation opioid” designed to limit oral overdose potential, according to a press release from its manufacturer.
Type 2 diabetes drug may reduce colorectal cancer risk
Glucagon-like peptide 1 receptor agonists significantly lowered the risk for colorectal cancer in patients with type 2 diabetes compared with other diabetes medications, according to a research letter in JAMA Oncology.
OK-101 achieves dry eye disease sign, symptom endpoints in phase 2 trial
Okyo Pharma announced positive safety and efficacy data from its phase 2 trial of OK-101 ophthalmic solution, a lipid-conjugated chemerin peptide agonist designed to reduce pain and inflammation in patients with dry eye disease.
The year in pain: Healio’s top 2023 stories on opioids, chronic pain myths and management
The state of pain management in rheumatology has always been in flux.
Oculis begins phase 3 trial of new steroid for post-cataract surgery pain, inflammation
Oculis has completed the first patient visit in its phase 3 OPTIMIZE-2 trial of OCS-01, the company’s preservative-free, once-daily topical formulation of dexamethasone for treating pain and inflammation after cataract surgery.
First patient visit complete in phase 3 trial of OCS-01 for diabetic macular edema
Oculis has announced the first patient first visit in the second stage of its phase 3 DIAMOND-1 trial evaluating OCS-01, the company’s high-concentration formulation of dexamethasone for treatment of diabetic macular edema.
Hospital intervention increased STI testing among at-risk adolescents
A hospital in California increased testing for chlamydia and gonorrhea among high-risk adolescents by nearly fivefold in its pediatric ED by implementing several interventions, including preselected order panels for physicians and nurses.
Greater atopic dermatitis severity linked to worse quality of life in pediatric patients
Pediatric patients with severe atopic dermatitis experienced higher rates of itch, pain, sleep disturbances and missed school days compared with those with mild disease, according to a study.
Odds of opioid use in autoimmune rheumatic disease decreased 15% annually after 2014
SAN DIEGO — The likelihood of opioid use among patients with autoimmune rheumatic disease has decreased annually by 15% since 2014, according to data presented at ACR Convergence 2023.